Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Studies of 18F-CETO as a Tracer for Adrenal PET Diagnostics

NCT05361083 is registered in ClinicalTrials.gov with Uppsala University as lead sponsor.

NCT NCT05361083
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05361083 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Studies of 18F-CETO as a Tracer for Adrenal PET Diagnostics
Lead sponsor
Uppsala University
Phase
Phase 1
Overall status
Completed
Start date
September 1, 2019
Completion date
February 28, 2022
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adrenal cushing syndrome, adrenocortical carcinoma, non-secretory adrenal adenoma, primary aldosteronism due to aldosterone producing adenoma, primary aldosteronism due to nodular hyperplasia